JB Jonas - Ophthalmic Res, 2006 - content.karger.com Background: Based on experimental studies and clinical observations by Robert
Machemer, Gholam Peyman and others, the vitreous cavity has increasingly been
used as a reservoir of drugs for the direct treatment of intraocular ... Cited by 46 - Related articles - BL Direct - All 5 versions
JT Thompson - American journal of ophthalmology, 2006 - Elsevier The mean visual acuity improved from 20/125 to −1 to 20/100 + 2 by one to two
months after injection (P < .001) and was 20/100 at the final examination (P =
.006) at a mean of 1.2 years after injection. Complications included a ... Cited by 43 - Related articles - All 21 versions
R Simo, E Carrasco, M Garcia-Ramirez, C … - Current Diabetes Reviews, 2006 - ingentaconnect.com Abstract: Diabetic retinopathy continues to be the leading cause of legal
blindness among working-age individuals. The earliest histological features of
diabetic retinopathy include neuroretinal damage, capillary basement ... Cited by 34 - Related articles - BL Direct - All 2 versions
JB Jonas, BA Kamppeter, B Harder, U … - Journal of Ocular Pharmacology & Therapeutics, 2006 - liebertonline.com Purpose: The aim of this study was to examine the visual outcome of patients
receiving an intravitreal injection of triamcinolone acetonide (TA) as treatment
of diffuse diabetic macu- lar edema (DDME). Methods: This prospective, ... Cited by 31 - Related articles - BL Direct - All 4 versions
DSC Lam, CKM Chan, S Mohamed, TYY Lai, … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: After ivTA injection, improvements of BCVA and CFT occurred in all
groups. The mean BCVA improvement at 6 months was significantly higher for the 8
mg group compared with the 4 mg group, with 9.9 and 3.1 improvement in ... Cited by 29 - Related articles - BL Direct - All 5 versions
JB Jonas, P Martus, RF Degenring, I Kreissig, … - Archives of Ophthalmology, 2005 - Am Med Assoc Results In a multiple linear regression analysis, maximum gain in best-corrected
visual acuity after the intravitreal injection of triamcinolone was
significantly (P < .001) and negatively correlated with an increased degree ... Cited by 28 - Related articles - BL Direct - All 4 versions
- ►duanesolution.com S Sivaprasad, P McCluskey, S Lightman - Acta Ophthalmologica Scandinavica, 2006 - pt.wkhealth.com The use of intravitreal corticosteroids in the management of macular oedema has
recently gained widespread acceptance. New long-acting steroid preparations and
methods of delivery have facilitated the use of these new modalities. This ... Cited by 29 - Related articles - BL Direct - All 6 versions
- ►nih.gov CKM Chan, S Mohamed, MP Shanmugam, CW … - British Journal of Ophthalmology, 2006 - bjo.bmj.com Results: BCVA, CFT, intraocular pressure (IOP), and cataract scores were not
significantly different before initial and repeat injections (given at 32.5 (SD
3.5) weeks after the first injection). Transient improvements of BCVA and ... Cited by 24 - Related articles - BL Direct - All 8 versions
M Vinten, M Larsen, H Lund-Andersen, B … - Acta Ophthalmologica Scandinavica, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 21 - Related articles - BL Direct - All 3 versions
